ENDONOVO THERAPEUTICS, INC. Deferred Compensation Equity
ENDONOVO THERAPEUTICS, INC. (ENDV) had Deferred Compensation Equity of $999.95 thousand as of 2019-09-30, per its 10-Q filed 2019-11-19.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2019-11-19
- 2019-09-30: Deferred Compensation Equity $999.95K.
- 2019-06-30: Deferred Compensation Equity $976.95K.
- 2019-03-31: Deferred Compensation Equity $940.45K.
- 2018-12-31: Deferred Compensation Equity $933.15K.
| Period end | Deferred Compensation Equity |
|---|---|
| 2019-09-30 | $999.95K 10-Q · filed 2019-11-19 |
| 2019-06-30 | $976.95K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $940.45K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $933.15K 10-Q · filed 2019-11-19 |